| Issue Type | XXXX |
|---|---|
| Country | Brazil |
| Industry | XXXX |
| Region | XXXX |
| Maturity Date | 2025-11-28 |
| Par Value | 8000 |
| Callable | XXXX |
| Next Call Date | XXXX |
| Call Type | XXXX |
| Call Price (%) | XXXX |
| Series | XXXX |
| Class | XXXX |
| Maturity Structure | XXXX |
| Amount Outstanding (mil) | 640.00 |
| Coupon | 13.65 |
|---|---|
| Coupon Type | XXXX |
| Coupon Frequency | XXXX |
| First Coupon Date | XXXX |
| Last Coupon Date | XXXX |
| Sinking Fund | XXXX |
|---|---|
| Security | XXXX |
| Subordination | XXXX |
| Debt Type | XXXX |
| Issue Date | XXXX |
|---|---|
| Dated Date | XXXX |
| Issue Size (mil) | 800 |
| Min. Piece | XXXX |
| Min. Increment | XXXX |
This Hypera S.A. corporate debenture has a X.X % floating rate rate coupon paid on a XXXX basis. It was issued on MAR 12, 2000 with an issue size of XXX million BRL and matures on DEC 9, 2000 with a last coupon date of FEB 28, 2020. |
Hypera S.A., founded in 2001 and headquartered in São Paulo, Brazil, is one of the leading pharmaceutical companies in the country, focusing on the research, development, manufacturing, and marketing of branded prescription medications and over-the-counter products. The company offers a diverse portfolio that includes pharmaceuticals, consumer health products, and diagnostics, catering to various therapeutic areas including central nervous system, cardiology, and oncology.